Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer ; volume:33 ; number:1 ; day:22 ; month:8 ; year:2014 ; pages:1-6 ; date:12.2014
Journal of experimental & clinical cancer research ; 33, Heft 1 (22.8.2014), 1-6, 12.2014
- Classification
-
Medizin, Gesundheit
- Creator
-
Lin, Ying-Li
Wang, Yan-Ling
Ma, Jian-Guo
Li, Wen-Ping
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-014-0068-7
- URN
-
urn:nbn:de:101:1-2019060923363518673679
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lin, Ying-Li
- Wang, Yan-Ling
- Ma, Jian-Guo
- Li, Wen-Ping
- SpringerLink (Online service)
Other Objects (12)
Clinical significance of subepithelial growth patterns in non-muscle invasive bladder cancer
Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis
Prognostic significance of SNCA and its methylation in bladder cancer
FOXM1 predicts disease progression in non-muscle invasive bladder cancer
Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
Significance of promoter methylation of multiple tumor suppressor genes in hepatocellular carcinoma
Follow-up in non-muscle invasive bladder cancer: facts and future
A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients
Prognostic significance of factor XIIIA promoter methylation status in aneurysmal subarachnoid haemorrhage (aSAH)
Metastatic non-muscle invasive transitional cell carcinoma of urinary bladder: a case report
Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
Precise grading of non-muscle invasive bladder cancer with multi-scale pyramidal CNN
Clinical significance of subepithelial growth patterns in non-muscle invasive bladder cancer
Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis
Prognostic significance of SNCA and its methylation in bladder cancer
FOXM1 predicts disease progression in non-muscle invasive bladder cancer
Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
Significance of promoter methylation of multiple tumor suppressor genes in hepatocellular carcinoma
Follow-up in non-muscle invasive bladder cancer: facts and future
A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients
Prognostic significance of factor XIIIA promoter methylation status in aneurysmal subarachnoid haemorrhage (aSAH)
Metastatic non-muscle invasive transitional cell carcinoma of urinary bladder: a case report
Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
Precise grading of non-muscle invasive bladder cancer with multi-scale pyramidal CNN
Clinical significance of subepithelial growth patterns in non-muscle invasive bladder cancer
Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis
Prognostic significance of SNCA and its methylation in bladder cancer
FOXM1 predicts disease progression in non-muscle invasive bladder cancer
Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
Significance of promoter methylation of multiple tumor suppressor genes in hepatocellular carcinoma
Follow-up in non-muscle invasive bladder cancer: facts and future
A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients
Prognostic significance of factor XIIIA promoter methylation status in aneurysmal subarachnoid haemorrhage (aSAH)
Metastatic non-muscle invasive transitional cell carcinoma of urinary bladder: a case report
Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer